Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
RockStep Solutions
United States
- Portland, Maine
- 30/08/2022
- Series A
- $5,300,000
RockStep is digitally transforming in vivo research with Climb, our collaboration suite for managing in vivo operations and data.
Quickly gaining traction in tier-1 pharma, biotechs, CROs, and Academia, Climb reduces data silos and streamlines research- enabling labs to get more science done!
- Industry Software Development
- Website https://www.rockstepsolutions.com/
- LinkedIn https://www.linkedin.com/company/rockstep-solutions/
Related People
Chuck DonnellyCo Founder
United States -
Portland, Maine Metropolitan Area
I am an investor and entrepreneur with a passion for building profitable scalable businesses with excellent business culture. I focus on market, financials, process, people, and results. I believe that successful companies consider their employees and customers as a team that together create value and success.
As CEO of RockStep Solutions, I work closely with my leadership team in developing and implementing a global growth strategy as the company transitions from start-up to scale-up.
"Great companies have great teams that build transformational products for large markets."
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)